扬子江药业集团：枳壳香飘沅江岸 产业铺就共富路

Core Viewpoint - The article highlights the efforts of Yangtze River Pharmaceutical Group in promoting the standardized cultivation of Zhi fruit (枳壳) in Yuanjiang, Hunan, enhancing local agricultural development and product quality through collaboration and technological innovation [1][4]. Group 1: Company Initiatives - Yangtze River Pharmaceutical Group has established a standardized cultivation base for Zhi fruit in collaboration with local partners, aiming to transform local natural resources into high-quality products [1][2]. - The company emphasizes quality control by sending Zhi fruit for third-party testing, ensuring compliance with standards, which is crucial for brand building [2][3]. - The cultivation area for Zhi fruit has expanded from over 200 acres to more than 1,000 acres, with an annual production capacity exceeding 5,000 tons [4]. Group 2: Technological Advancements - Yangtze River Pharmaceutical Group has developed 81 management documents and 12 specific management files for Zhi fruit cultivation, enhancing quality from the source [3]. - The company utilizes digital technology to establish a transparent and traceable quality management system, improving efficiency and accuracy in the inspection of traditional Chinese medicine [3]. - Automation and intelligent systems are being integrated into the production process, enhancing the stability of product quality [3]. Group 3: Industry Impact - The stable demand from Yangtze River Pharmaceutical Group encourages local farmers to cultivate Zhi fruit, thereby boosting rural economic development [4]. - The local government has set a target to add 1 million standardized Zhi fruit plants by the end of 2029, with an annual increase of 200,000 plants, indicating a strong commitment to industry growth [4].